BraTS-Path Challenge: Assessing Heterogeneous Histopathologic Brain Tumor Sub-regions
Authors:
Spyridon Bakas,
Siddhesh P. Thakur,
Shahriar Faghani,
Mana Moassefi,
Ujjwal Baid,
Verena Chung,
Sarthak Pati,
Shubham Innani,
Bhakti Baheti,
Jake Albrecht,
Alexandros Karargyris,
Hasan Kassem,
MacLean P. Nasrallah,
Jared T. Ahrendsen,
Valeria Barresi,
Maria A. Gubbiotti,
Giselle Y. López,
Calixto-Hope G. Lucas,
Michael L. Miller,
Lee A. D. Cooper,
Jason T. Huse,
William R. Bell
Abstract:
Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise. Glioblastoma is widely infiltrative in the cerebral hemispheres and well-defined by heterogeneous molecular and micro-environmental histopathologic profiles, which pose a major obstacle in treatment. Correctly diagnosing these tumors and as…
▽ More
Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise. Glioblastoma is widely infiltrative in the cerebral hemispheres and well-defined by heterogeneous molecular and micro-environmental histopathologic profiles, which pose a major obstacle in treatment. Correctly diagnosing these tumors and assessing their heterogeneity is crucial for choosing the precise treatment and potentially enhancing patient survival rates. In the gold-standard histopathology-based approach to tumor diagnosis, detecting various morpho-pathological features of distinct histology throughout digitized tissue sections is crucial. Such "features" include the presence of cellular tumor, geographic necrosis, pseudopalisading necrosis, areas abundant in microvascular proliferation, infiltration into the cortex, wide extension in subcortical white matter, leptomeningeal infiltration, regions dense with macrophages, and the presence of perivascular or scattered lymphocytes. With these features in mind and building upon the main aim of the BraTS Cluster of Challenges https://www.synapse.org/brats2024, the goal of the BraTS-Path challenge is to provide a systematically prepared comprehensive dataset and a benchmarking environment to develop and fairly compare deep-learning models capable of identifying tumor sub-regions of distinct histologic profile. These models aim to further our understanding of the disease and assist in the diagnosis and grading of conditions in a consistent manner.
△ Less
Submitted 17 May, 2024;
originally announced May 2024.
Detecting Histologic & Clinical Glioblastoma Patterns of Prognostic Relevance
Authors:
Bhakti Baheti,
Sunny Rai,
Shubham Innani,
Garv Mehdiratta,
Sharath Chandra Guntuku,
MacLean P. Nasrallah,
Spyridon Bakas
Abstract:
Glioblastoma is the most common and aggressive malignant adult tumor of the central nervous system, with a grim prognosis and heterogeneous morphologic and molecular profiles. Since adopting the current standard-of-care treatment 18 years ago, no substantial prognostic improvement has been noticed. Accurate prediction of patient overall survival (OS) from histopathology whole slide images (WSI) in…
▽ More
Glioblastoma is the most common and aggressive malignant adult tumor of the central nervous system, with a grim prognosis and heterogeneous morphologic and molecular profiles. Since adopting the current standard-of-care treatment 18 years ago, no substantial prognostic improvement has been noticed. Accurate prediction of patient overall survival (OS) from histopathology whole slide images (WSI) integrated with clinical data using advanced computational methods could optimize clinical decision-making and patient management. Here, we focus on identifying prognostically relevant glioblastoma characteristics from H&E stained WSI & clinical data relating to OS. The exact approach for WSI capitalizes on the comprehensive curation of apparent artifactual content and an interpretability mechanism via a weakly supervised attention-based multiple-instance learning algorithm that further utilizes clustering to constrain the search space. The automatically placed patterns of high diagnostic value classify each WSI as representative of short or long-survivors. Further assessment of the prognostic relevance of the associated clinical patient data is performed both in isolation and in an integrated manner, using XGBoost and SHapley Additive exPlanations (SHAP). Identifying tumor morphological & clinical patterns associated with short and long OS will enable the clinical neuropathologist to provide additional relevant prognostic information to the treating team and suggest avenues of biological investigation for understanding and potentially treating glioblastoma.
△ Less
Submitted 15 May, 2023; v1 submitted 1 February, 2023;
originally announced February 2023.
